COVID-19: A Brief Overview of the Discovery Clinical Trial
The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the Europe...
Main Author: | Jean Jacques Vanden Eynde |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/4/65 |
Similar Items
-
COVID-19: An Update about the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-05-01) -
Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)
by: Abhi Bhadra, et al.
Published: (2020-05-01) -
Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
by: Milo Gatti, et al.
Published: (2021-02-01) -
Pharmacological management of COVID-19
by: Veena Raghunathan, et al.
Published: (2020-01-01) -
Therapeutic Strategies in the Management of COVID-19
by: Rajashri R. Naik, et al.
Published: (2021-02-01)